The Use of Zoledronic Acid to Prevent Cancer-treatment Bone Loss in Post-menopausal Women Receiving Adjuvant Letrozole for Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

527

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

November 30, 2010

Conditions
Breast Cancer
Interventions
DRUG

Zoledronic acid

Zoledronic acid 4 mg Intravenous (IV)15 minute infusion every 6 months.

DRUG

Letrozole

Letrozole tablets 2.5 mg/day/taken orally for 5 years.

Trial Locations (49)

Unknown

Novartis Investigative Site, Buenos Aires

Novartis Investigative Site, Rosario - Santa Fe

Novartis Investigative Site, Aalst

Novartis Investigative Site, Anderlecht

Novartis Investigative Site, Bonheiden

Novartis Investigative Site, Brasschaat

Novartis Investigative Site, Brussels

Novartis Investigative Site, Edegem

Novartis Investigative Site, Hasselt

Novartis Investigative Site, Leuven

Novartis Investigative Site, Libramont-Chevigny

Novartis Investigative Site, Liège

Novartis Investigative Site, Mons

Novartis Investigative Site, Ottignies

Novartis Investigative Site, Saint Niklaas

Novartis Investigative Site, Wilrijk

Novartis Investigative Site, Yvoir

Novartis Investigative Site, Limoges

Novartis Investigative Site, Mougins

Novartis Investigative Site, Périgueux

Novartis Investigative Site, Rennes

Novartis Investigative Site, Saint-Brieuc

Novartis Investigative Site, Saint-Herblain

Novartis Investigative Site, Toulon

Novartis Investigative Site, Vandœuvre-lès-Nancy

Novartis Investigative Site, Genova

Novartis Investigative Site, Ivrea

Novartis Investigative Site, Lecco

Novartis Investigative Site, Monteforte Irpino (Av)

Novartis Investigative Site, Pietra Ligure

Novartis Investigative Site, Roma

Novartis Investigative Site, Sassari

Novartis Investigative Site, Torino

Novartis Investigative Site, Vicenza

Novartis Investigative Site, Eindhoven

Novartis Investigative Site, Hoogeveen

Novartis Investigative Site, Nijmegen

Novartis Investigative Site, The Hague

Novartis Investigative Site, Riyadh

Novartis Investigative Site, Cape Town

Novartis Investigative Site, Durban

Novartis Investigative Site, Johannesburg

Novartis Investigative Site, Daegu

Novartis Investigative Site, Jeollanam-do

Novartis Investigative Site, Seoul

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Córdoba

Novartis Investigative Site, Madrid

Novartis Investigative Site, Valencia

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY